Related Experiment Video
Updated: Feb 19, 2026

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
Published on: April 24, 2020
The Effect of a Decrease in Intraocular Pressure on Optic Nerve Function in Patients with Optic Nerve Drusen.
Dorota Pojda-Wilczek1, Patrycja Wycisło-Gawron
1Department of Ophthalmology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
Lowering intraocular pressure (IOP) with brinzolamide improved optic nerve function in patients with optic disk drusen (ODD). This treatment stabilized retinal nerve fiber layer thickness and enhanced visual function, suggesting a protective effect against optic neuropathy progression.
Area of Science:
- Ophthalmology
- Neuroscience
Background:
- Optic disk drusen (ODD) can lead to optic neuropathy.
- Intraocular pressure (IOP) is a key factor in optic nerve health.
Purpose of the Study:
- To compare optic nerve function in eyes with brinzolamide-treated ODD and fellow control eyes.
- To evaluate the effect of IOP reduction on ODD-related optic neuropathy.
Main Methods:
- 34 patients with bilateral ODD were included.
- Brinzolamide was used to lower IOP in affected eyes; fellow eyes served as controls.
- Evaluations included visual field testing, pattern electroretinography (PERG), pattern visual-evoked potentials (PVEP), and retinal nerve fiber layer (RNFL) thickness measurements over 12 months.
Main Results:
- Brinzolamide-treated eyes showed improved visual field indices and increased PERG N95 amplitude.
- RNFL thickness stabilized in treated eyes.
- Control eyes exhibited a significant decrease in RNFL thickness.
Conclusions:
- Reduced IOP in ODD eyes improves retinal ganglion cell function and delays optic neuropathy progression.
- Pattern electroretinography (PERG) is a sensitive tool for monitoring ODD-related optic neuropathy.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Photoreceptors and Visual Pathways

